Chenghui Li
Concepts (214)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Prostatic Neoplasms | 4 | 2024 | 394 | 2.730 |
Why?
| Breast Neoplasms | 7 | 2024 | 1174 | 1.800 |
Why?
| Chronic Pain | 8 | 2024 | 165 | 1.500 |
Why?
| Medicare | 7 | 2024 | 246 | 1.500 |
Why?
| Healthcare Disparities | 2 | 2024 | 257 | 1.460 |
Why?
| Medicaid | 6 | 2023 | 257 | 1.450 |
Why?
| United States | 25 | 2024 | 4860 | 1.250 |
Why?
| Analgesics, Opioid | 11 | 2024 | 552 | 1.250 |
Why?
| Aged | 26 | 2024 | 9310 | 1.090 |
Why?
| Retrospective Studies | 26 | 2024 | 6108 | 0.940 |
Why?
| Antineoplastic Agents, Hormonal | 1 | 2024 | 47 | 0.940 |
Why?
| Patient Care | 4 | 2024 | 55 | 0.880 |
Why?
| Medication Adherence | 1 | 2024 | 128 | 0.870 |
Why?
| Humans | 48 | 2024 | 49974 | 0.860 |
Why?
| Prostate | 4 | 2024 | 117 | 0.850 |
Why?
| Developmental Disabilities | 1 | 2023 | 119 | 0.840 |
Why?
| Poverty | 1 | 2024 | 201 | 0.840 |
Why?
| Conduct Disorder | 1 | 2022 | 9 | 0.830 |
Why?
| Back Pain | 2 | 2021 | 39 | 0.820 |
Why?
| Intellectual Disability | 1 | 2023 | 125 | 0.810 |
Why?
| Pharmacy | 1 | 2023 | 58 | 0.800 |
Why?
| Carcinoma, Non-Small-Cell Lung | 1 | 2023 | 154 | 0.780 |
Why?
| SEER Program | 5 | 2024 | 94 | 0.770 |
Why?
| Students, Pharmacy | 1 | 2023 | 121 | 0.760 |
Why?
| Insurance Coverage | 3 | 2024 | 103 | 0.760 |
Why?
| Mental Disorders | 3 | 2015 | 396 | 0.750 |
Why?
| Medical Records Systems, Computerized | 2 | 2011 | 38 | 0.740 |
Why?
| Education, Pharmacy | 1 | 2023 | 143 | 0.730 |
Why?
| Adult | 24 | 2024 | 13236 | 0.710 |
Why?
| Premature Birth | 1 | 2022 | 147 | 0.700 |
Why?
| Brain Neoplasms | 1 | 2023 | 287 | 0.700 |
Why?
| Female | 32 | 2024 | 26472 | 0.700 |
Why?
| Male | 27 | 2024 | 25241 | 0.660 |
Why?
| Middle Aged | 22 | 2024 | 12069 | 0.650 |
Why?
| Adolescent | 12 | 2024 | 6356 | 0.610 |
Why?
| Osteoarthritis | 1 | 2018 | 62 | 0.600 |
Why?
| Lung Neoplasms | 1 | 2023 | 606 | 0.590 |
Why?
| Young Adult | 11 | 2024 | 3958 | 0.560 |
Why?
| Antipsychotic Agents | 3 | 2014 | 232 | 0.540 |
Why?
| Arkansas | 7 | 2024 | 1977 | 0.540 |
Why?
| Quality of Life | 2 | 2018 | 836 | 0.510 |
Why?
| Bupropion | 1 | 2015 | 32 | 0.510 |
Why?
| Pneumococcal Vaccines | 1 | 2015 | 8 | 0.510 |
Why?
| Pneumonia, Pneumococcal | 1 | 2015 | 10 | 0.500 |
Why?
| Community-Acquired Infections | 1 | 2015 | 39 | 0.490 |
Why?
| Influenza Vaccines | 1 | 2015 | 30 | 0.480 |
Why?
| Drug Overdose | 4 | 2022 | 159 | 0.470 |
Why?
| Alcoholism | 3 | 2021 | 232 | 0.460 |
Why?
| Cross-Sectional Studies | 4 | 2024 | 1557 | 0.460 |
Why?
| Socioeconomic Factors | 3 | 2024 | 581 | 0.450 |
Why?
| Atrial Fibrillation | 2 | 2015 | 180 | 0.440 |
Why?
| Aged, 80 and over | 7 | 2023 | 3129 | 0.430 |
Why?
| Tramadol | 2 | 2024 | 30 | 0.430 |
Why?
| Databases, Factual | 4 | 2024 | 658 | 0.430 |
Why?
| Drug Prescriptions | 2 | 2021 | 95 | 0.420 |
Why?
| Tobacco Use Cessation | 1 | 2012 | 8 | 0.410 |
Why?
| Neoplasms | 1 | 2022 | 1235 | 0.410 |
Why?
| Neuralgia | 2 | 2023 | 62 | 0.410 |
Why?
| Smoking Cessation | 1 | 2015 | 299 | 0.400 |
Why?
| Polypharmacy | 1 | 2011 | 14 | 0.400 |
Why?
| Practice Management, Medical | 1 | 2011 | 12 | 0.400 |
Why?
| Minority Groups | 2 | 2023 | 132 | 0.390 |
Why?
| Smoking | 1 | 2015 | 511 | 0.390 |
Why?
| Anti-Arrhythmia Agents | 1 | 2011 | 79 | 0.390 |
Why?
| Insurance, Health | 2 | 2024 | 126 | 0.380 |
Why?
| Adrenergic beta-Antagonists | 1 | 2011 | 102 | 0.380 |
Why?
| Emergency Service, Hospital | 2 | 2016 | 486 | 0.380 |
Why?
| Medical Informatics | 1 | 2011 | 49 | 0.380 |
Why?
| Attitude to Computers | 1 | 2010 | 18 | 0.360 |
Why?
| Medically Underserved Area | 1 | 2010 | 42 | 0.350 |
Why?
| Analgesics, Non-Narcotic | 1 | 2011 | 117 | 0.350 |
Why?
| Insurance Claim Review | 2 | 2024 | 36 | 0.340 |
Why?
| Opioid-Related Disorders | 3 | 2022 | 381 | 0.330 |
Why?
| Child | 5 | 2024 | 6847 | 0.320 |
Why?
| Acetaminophen | 1 | 2011 | 283 | 0.300 |
Why?
| Health Services Accessibility | 2 | 2022 | 398 | 0.290 |
Why?
| Propensity Score | 4 | 2022 | 123 | 0.280 |
Why?
| Attitude of Health Personnel | 1 | 2010 | 347 | 0.280 |
Why?
| Health Care Surveys | 3 | 2011 | 173 | 0.280 |
Why?
| Health Care Costs | 2 | 2024 | 170 | 0.260 |
Why?
| Odds Ratio | 4 | 2020 | 545 | 0.250 |
Why?
| Substance-Related Disorders | 2 | 2021 | 600 | 0.250 |
Why?
| Poverty Areas | 1 | 2024 | 31 | 0.240 |
Why?
| Child, Preschool | 3 | 2024 | 3871 | 0.240 |
Why?
| Receptors, Progesterone | 1 | 2024 | 63 | 0.240 |
Why?
| Patient Protection and Affordable Care Act | 2 | 2021 | 50 | 0.230 |
Why?
| Ileus | 1 | 2023 | 15 | 0.230 |
Why?
| Cohort Studies | 6 | 2022 | 1422 | 0.230 |
Why?
| Receptors, Estrogen | 1 | 2024 | 130 | 0.230 |
Why?
| Obesity | 1 | 2011 | 1113 | 0.220 |
Why?
| Confidence Intervals | 3 | 2013 | 156 | 0.210 |
Why?
| Activities of Daily Living | 1 | 2023 | 174 | 0.210 |
Why?
| Radiation Injuries | 1 | 2023 | 113 | 0.200 |
Why?
| Prescriptions | 1 | 2021 | 10 | 0.200 |
Why?
| Colonic Neoplasms | 1 | 2023 | 161 | 0.200 |
Why?
| Health Expenditures | 1 | 2022 | 67 | 0.200 |
Why?
| Respiratory Insufficiency | 1 | 2023 | 113 | 0.200 |
Why?
| Neck Pain | 1 | 2021 | 10 | 0.200 |
Why?
| Arthralgia | 1 | 2021 | 43 | 0.190 |
Why?
| Professional-Patient Relations | 1 | 2021 | 47 | 0.190 |
Why?
| Heart Diseases | 1 | 2023 | 206 | 0.190 |
Why?
| Infant | 2 | 2024 | 3567 | 0.190 |
Why?
| Patient Acceptance of Health Care | 1 | 2024 | 329 | 0.180 |
Why?
| Hypertension | 2 | 2018 | 533 | 0.180 |
Why?
| Veterans | 5 | 2021 | 555 | 0.180 |
Why?
| Neoplasm Micrometastasis | 1 | 2020 | 7 | 0.180 |
Why?
| Anxiety | 1 | 2022 | 274 | 0.180 |
Why?
| Curriculum | 1 | 2023 | 401 | 0.170 |
Why?
| Registries | 1 | 2023 | 522 | 0.170 |
Why?
| Hawaii | 1 | 2020 | 114 | 0.170 |
Why?
| Preventive Health Services | 1 | 2020 | 51 | 0.170 |
Why?
| Multivariate Analysis | 2 | 2011 | 577 | 0.170 |
Why?
| Arterial Pressure | 1 | 2018 | 43 | 0.160 |
Why?
| Practice Guidelines as Topic | 3 | 2016 | 449 | 0.160 |
Why?
| Sleep Deprivation | 1 | 2018 | 17 | 0.160 |
Why?
| Vancomycin | 1 | 2018 | 81 | 0.150 |
Why?
| Vasoconstrictor Agents | 1 | 2018 | 84 | 0.150 |
Why?
| Metabolic Diseases | 1 | 2018 | 40 | 0.150 |
Why?
| Logistic Models | 2 | 2011 | 888 | 0.150 |
Why?
| Shock, Septic | 1 | 2018 | 78 | 0.150 |
Why?
| Risk Factors | 4 | 2018 | 3613 | 0.150 |
Why?
| Depression | 1 | 2022 | 568 | 0.140 |
Why?
| Ganciclovir | 1 | 2016 | 24 | 0.140 |
Why?
| Cytomegalovirus | 1 | 2016 | 27 | 0.140 |
Why?
| Cytomegalovirus Infections | 1 | 2016 | 34 | 0.140 |
Why?
| Antibiotic Prophylaxis | 1 | 2016 | 61 | 0.140 |
Why?
| Inappropriate Prescribing | 1 | 2016 | 18 | 0.130 |
Why?
| Drug Therapy, Combination | 2 | 2018 | 377 | 0.130 |
Why?
| Nicotinic Agonists | 1 | 2015 | 56 | 0.130 |
Why?
| Decision Support Techniques | 1 | 2015 | 70 | 0.130 |
Why?
| Antiviral Agents | 1 | 2016 | 173 | 0.130 |
Why?
| Acute Kidney Injury | 1 | 2018 | 284 | 0.120 |
Why?
| Length of Stay | 2 | 2015 | 619 | 0.120 |
Why?
| Hospitals, Veterans | 1 | 2015 | 110 | 0.120 |
Why?
| Kidney Transplantation | 1 | 2016 | 175 | 0.120 |
Why?
| Follow-Up Studies | 4 | 2024 | 2182 | 0.120 |
Why?
| Hyperglycemia | 1 | 2014 | 79 | 0.120 |
Why?
| Venous Thromboembolism | 1 | 2015 | 68 | 0.120 |
Why?
| Hydrocodone | 2 | 2024 | 20 | 0.110 |
Why?
| Oxycodone | 2 | 2024 | 27 | 0.110 |
Why?
| Cholesterol, LDL | 1 | 2013 | 34 | 0.110 |
Why?
| Anticoagulants | 1 | 2015 | 250 | 0.110 |
Why?
| Anti-Bacterial Agents | 1 | 2018 | 744 | 0.110 |
Why?
| Cardiovascular Diseases | 1 | 2018 | 440 | 0.110 |
Why?
| Hospital Mortality | 1 | 2015 | 409 | 0.110 |
Why?
| Drug Substitution | 1 | 2011 | 9 | 0.100 |
Why?
| Office Visits | 1 | 2011 | 41 | 0.100 |
Why?
| Severity of Illness Index | 1 | 2015 | 945 | 0.100 |
Why?
| Hyperlipidemias | 1 | 2011 | 49 | 0.100 |
Why?
| Hospitalization | 1 | 2016 | 652 | 0.100 |
Why?
| Linear Models | 1 | 2011 | 280 | 0.090 |
Why?
| Choice Behavior | 1 | 2011 | 85 | 0.090 |
Why?
| Regression Analysis | 1 | 2011 | 395 | 0.090 |
Why?
| Body Weight | 1 | 2013 | 513 | 0.090 |
Why?
| Physicians' Offices | 1 | 2010 | 5 | 0.090 |
Why?
| Information Systems | 1 | 2010 | 27 | 0.090 |
Why?
| Ambulatory Care | 1 | 2011 | 222 | 0.090 |
Why?
| Blood Glucose | 1 | 2013 | 439 | 0.090 |
Why?
| Weight Gain | 1 | 2011 | 240 | 0.090 |
Why?
| Statistics, Nonparametric | 1 | 2010 | 194 | 0.090 |
Why?
| Case-Control Studies | 2 | 2023 | 1131 | 0.090 |
Why?
| Patients | 1 | 2010 | 49 | 0.090 |
Why?
| Comorbidity | 1 | 2011 | 615 | 0.090 |
Why?
| Time Factors | 2 | 2016 | 2903 | 0.080 |
Why?
| Pain Measurement | 2 | 2021 | 240 | 0.080 |
Why?
| Models, Statistical | 1 | 2010 | 224 | 0.080 |
Why?
| Guideline Adherence | 2 | 2023 | 133 | 0.080 |
Why?
| Diabetes Mellitus | 1 | 2011 | 285 | 0.080 |
Why?
| Age Factors | 1 | 2011 | 1087 | 0.070 |
Why?
| United States Department of Veterans Affairs | 2 | 2020 | 285 | 0.070 |
Why?
| Incidence | 2 | 2018 | 1003 | 0.060 |
Why?
| Anastomotic Leak | 1 | 2023 | 10 | 0.060 |
Why?
| Colectomy | 1 | 2023 | 30 | 0.060 |
Why?
| Prevalence | 2 | 2018 | 944 | 0.060 |
Why?
| Biological Factors | 1 | 2023 | 10 | 0.060 |
Why?
| Heart Atria | 1 | 2023 | 55 | 0.060 |
Why?
| Analgesics | 1 | 2023 | 100 | 0.050 |
Why?
| Accidents | 1 | 2021 | 21 | 0.050 |
Why?
| Patient Readmission | 1 | 2023 | 219 | 0.050 |
Why?
| Heart | 1 | 2023 | 326 | 0.050 |
Why?
| Radiotherapy, Adjuvant | 1 | 2020 | 56 | 0.040 |
Why?
| Pain | 1 | 2022 | 379 | 0.040 |
Why?
| Reproducibility of Results | 1 | 2023 | 1193 | 0.040 |
Why?
| Needs Assessment | 1 | 2020 | 133 | 0.040 |
Why?
| Mastectomy | 1 | 2020 | 140 | 0.040 |
Why?
| Delivery of Health Care | 1 | 2021 | 309 | 0.040 |
Why?
| Goals | 1 | 2018 | 40 | 0.040 |
Why?
| Depressive Disorder, Major | 1 | 2020 | 151 | 0.040 |
Why?
| Quality of Health Care | 1 | 2020 | 186 | 0.040 |
Why?
| Survival Analysis | 1 | 2020 | 653 | 0.040 |
Why?
| Physicians | 1 | 2021 | 233 | 0.040 |
Why?
| Health Surveys | 1 | 2018 | 232 | 0.040 |
Why?
| Rats | 1 | 2023 | 3305 | 0.040 |
Why?
| Serologic Tests | 1 | 2016 | 26 | 0.040 |
Why?
| Postoperative Complications | 1 | 2023 | 984 | 0.040 |
Why?
| Opportunistic Infections | 1 | 2016 | 58 | 0.030 |
Why?
| Critical Illness | 1 | 2018 | 288 | 0.030 |
Why?
| Survival Rate | 1 | 2018 | 894 | 0.030 |
Why?
| Longitudinal Studies | 1 | 2018 | 688 | 0.030 |
Why?
| Graft Rejection | 1 | 2016 | 161 | 0.030 |
Why?
| Geriatrics | 1 | 2016 | 46 | 0.030 |
Why?
| Societies, Medical | 1 | 2016 | 175 | 0.030 |
Why?
| Costs and Cost Analysis | 1 | 2015 | 95 | 0.030 |
Why?
| Cost of Illness | 1 | 2015 | 117 | 0.030 |
Why?
| Time-to-Treatment | 1 | 2014 | 61 | 0.030 |
Why?
| Venous Thrombosis | 1 | 2015 | 90 | 0.030 |
Why?
| Pulmonary Embolism | 1 | 2015 | 97 | 0.030 |
Why?
| Hospitals | 1 | 2015 | 175 | 0.030 |
Why?
| Disease Management | 1 | 2014 | 174 | 0.030 |
Why?
| Recurrence | 1 | 2015 | 652 | 0.030 |
Why?
| Drug Monitoring | 1 | 2013 | 77 | 0.030 |
Why?
| Risk Assessment | 1 | 2015 | 1259 | 0.020 |
Why?
| Animals | 1 | 2023 | 13187 | 0.020 |
Why?
| Treatment Outcome | 1 | 2016 | 5141 | 0.020 |
Why?
|
|
Li's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|